Nancy Duitch insider trades: Cure Pharmaceutical Holding (CURR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Nancy reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 25, 2021 | CURR | ↑ Buy | 1,000 | $0.70 | $700 | By the Duitch Living Trust dated January | May 27, 2021 (2d) |
| May 21, 2021 | CURR | ↑ Buy | 5,000 | $0.73 | $4K | By the Duitch Living Trust dated January | May 24, 2021 (3d) |
| Dec 10, 2008 | VBDG | ↑ Buy | 20,000 | $0.13 | $3K | See Note | Dec 11, 2008 (1d) |
| Nov 27, 2007 | VBDG | ↑ Buy | 10,000 | $0.51 | $5K | See Note | Nov 28, 2007 (1d) |
| Jan 9, 2006 | MFCD | ↓ Sell | 11,750 | $1.04 | $12K | See Note | Jan 11, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Nancy Duitch's insider trades
Nancy Duitch is Chief Strategy Officer at Cure Pharmaceutical Holding (CURR). Since Jan 9, 2006, Nancy has reported 4 open-market purchases worth $12K and 1 sale worth $12K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CURR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.